Financials
- Market Capitalization 934.45 M
- Employee 489
- Founded 2007
- CEO Mike Raab
- Website www.ardelyx.com
- Headquarter Delaware, United States
- FIGI BBG001WH4DQ3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-22.17
ratio cours/chiffre d'affaires
2.76
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2455 | IMMX Immix Biopharma, Inc. - Common Stock | 13.78 USD | -1.64% | -1.92% | +66.63% | +526.36% | 985.81 M USD | ||
| 2465 | DSGN Design Therapeutics, Inc. - Common Stock | 15.58 USD | +2.91% | -1.08% | +29.40% | +174.30% | 975.02 M USD | ||
| 2484 | ANNX Annexon, Inc. - common stock | 4.87 USD | -0.41% | -3.94% | -3.75% | +137.56% | 923.25 M USD | ||
| 2488 | WVE Wave Life Sciences Ltd. - Ordinary Shares | 4.75 USD | -4.43% | -9.87% | -14.41% | -33.66% | 935.98 M USD |